Nama Insights

Tema Oncology ETF (CANC)

Health · Tema ETFs · NASDAQ

HealthETF
Tema Oncology ETF (CANC) is an exchange-traded fund in the Health category. It has $190.03M in assets, an expense ratio of 0.75% and a 0.05% dividend yield. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Assets under management$190.03M
Expense ratio0.75%
CategoryHealth
Dividend yield0.05%
NAV$40.27
Fund familyTema ETFs
ExchangeNASDAQ

Top holdings

The largest positions Tema Oncology ETF reports, by weight.

HoldingNameWeight
RVMD Revolution Medicines Inc Ordinary Shares 5.84%
LLY Eli Lilly and Co 4.89%
COGT Cogent Biosciences Inc 4.72%
NOVN.SW Novartis AG Registered Shares 3.96%
RHHBY Roche Holding AG ADR 3.67%
LEGN Legend Biotech Corp ADR 3.51%
MRK Merck & Co Inc 3.44%
BMY Bristol-Myers Squibb Co 3.14%
AZN.L AstraZeneca PLC 2.93%
JNJ Johnson & Johnson 2.91%

Other Health ETFs

Explore live CANC data on Nama Insights →